PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
6.44%
Similar revenue growth to 3088.T's 6.60%. Walter Schloss would investigate if similar growth reflects similar quality.
5.53%
Cost growth 50-75% of 3088.T's 8.23%. Bruce Berkowitz would examine sustainable cost advantages.
10.34%
Gross profit growth exceeding 1.5x 3088.T's 2.76%. David Dodd would verify competitive advantages.
3.67%
Margin expansion while 3088.T shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
-100.00%
Both companies reducing marketing spend. Martin Whitman would check industry trends.
-15.82%
Other expenses reduction while 3088.T shows 14.56% growth. Joel Greenblatt would examine efficiency.
2.61%
Similar operating expenses growth to 3088.T's 3.45%. Walter Schloss would investigate norms.
5.09%
Total costs growth 50-75% of 3088.T's 6.97%. Bruce Berkowitz would examine efficiency.
-15.38%
Both companies reducing interest expense. Martin Whitman would check industry trends.
-14.91%
D&A reduction while 3088.T shows 44.89% growth. Joel Greenblatt would examine efficiency.
32.32%
EBITDA growth exceeding 1.5x 3088.T's 2.11%. David Dodd would verify competitive advantages.
24.32%
EBITDA margin growth while 3088.T declines. John Neff would investigate advantages.
35.65%
Operating income growth while 3088.T declines. John Neff would investigate advantages.
27.45%
Operating margin growth while 3088.T declines. John Neff would investigate advantages.
-10.80%
Other expenses reduction while 3088.T shows 106.62% growth. Joel Greenblatt would examine advantage.
32.47%
Pre-tax income growth exceeding 1.5x 3088.T's 8.40%. David Dodd would verify competitive advantages.
24.46%
Pre-tax margin growth exceeding 1.5x 3088.T's 1.69%. David Dodd would verify competitive advantages.
27.04%
Tax expense growth while 3088.T reduces burden. John Neff would investigate differences.
36.95%
Net income growth exceeding 1.5x 3088.T's 18.50%. David Dodd would verify competitive advantages.
28.66%
Net margin growth exceeding 1.5x 3088.T's 11.17%. David Dodd would verify competitive advantages.
-31.52%
EPS decline while 3088.T shows 18.50% growth. Joel Greenblatt would examine position.
-31.52%
Diluted EPS decline while 3088.T shows 14.99% growth. Joel Greenblatt would examine position.
100.00%
Share count change of 100.00% while 3088.T is stable. Bruce Berkowitz would verify approach.
100.00%
Diluted share change of 100.00% while 3088.T is stable. Bruce Berkowitz would verify approach.